Filter
832
Filtered Results: 832
Text search:
vaccine
readiness
Featured
Recommendations
123
New Publications
222
Language
Document type
No document type
339
Guidelines
150
Studies & Reports
125
Strategic & Response Plan
83
Manuals
64
Fact sheets
28
Situation Updates
19
Training Material
11
Resource Platforms
9
Online Courses
2
App
1
Infographics
1
Countries / Regions
Global
41
India
38
Kenya
33
Sierra Leone
23
Nigeria
21
Liberia
17
Ethiopia
17
Nepal
16
Congo, Democratic Republic of
15
Syria
15
Africa
15
Tanzania
14
Bangladesh
14
South Africa
13
Latin America and the Carribbean
11
Russia
11
Ghana
10
Uganda
10
Malawi
10
Myanmar / Burma
10
Zambia
9
Ukraine
9
Pakistan
8
Rwanda
8
East and Southern Africa
8
Western and Central Europe
8
Senegal
7
West and Central Africa
7
South–East Asia Region
7
Philippines
6
South Sudan
6
Mozambique
6
Brazil
6
Middle East and North Africa
6
Western Pacific Region
6
Guinea
5
Zimbabwe
5
Afghanistan
5
Indonesia
5
Eastern Europe and Central Asia
5
Namibia
4
Lesotho
4
Mali
3
Somalia
3
Benin
3
Central African Republic
3
Eswatini/ Swaziland
3
Burundi
3
Yemen
3
Moldova
3
Côte d’Ivoire / Ivory Coast
2
Cameroon
2
Turkey
2
Thailand
2
China
2
Botswana
2
Eastern Europe
2
Burkina Faso
1
Guinea-Bissau
1
Haiti
1
Iraq
1
Jordan
1
Lebanon
1
Egypt
1
Chad
1
Cambodia
1
Malaysia
1
Sudan
1
Ecuador
1
El Salvador
1
Angola
1
Chile
1
Asia
1
Southern Africa
1
Timor Leste/ East Timor
1
Georgia
1
Vietnam
1
Turkmenistan
1
Japan
1
Mauritius
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
354
Clinical Guidelines
60
Public Health
49
Key Resources
43
Women & Child Health
34
Pharmacy & Technologies
12
Capacity Building
8
Toolboxes
COVID-19
222
Rapid Response
70
Ebola
40
HIV
30
Conflict
23
AMR
18
TB
16
Polio
15
Caregiver
13
Global Health Education
11
Cholera
9
Natural Hazards
8
Health Financing Toolbox
8
Zika
7
Planetary Health
7
Pharmacy
7
NTDs
6
Refugee
5
NCDs
5
Mental Health
3
Specific Hazards
2
Disability
1
Introduction: Considering the global prevalence of coronavirus disease 2019 (COVID-19), a vaccine is being developed to control the disease as a complementary solution to hygiene measures—and better, in social terms, than social distancing. Given that a vaccine will eventually be produced, informa...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
More than two years since the first SARS-CoV-2 infections were reported, the COVID-19 pandemic remains an acute global emergency. In this Strategic Preparedness, Readiness and Response plan for 2022, WHO sets out a number of key strategic adjustments that, if implemented rapidly and consistently at ...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
Cholera is a major health risk in many parts of the world, affecting millions of people every year. Since mid-2021, the world has been facing an acute upsurge of the 7th cholera pandemic, which is characterized by the number, size and concurrence of multiple outbreaks, the spread to areas that had b...
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident...
This guide is intended to support national governments developing their national deployment and vaccination plans (NDVPs) for COVID-19 vaccines by outlining the roles, needs and opportunities for community health workers (CHWs) to contribute. This note builds on and is structured to align with the G...
The overall goal of this strategy is to ensure accurate understanding of the
benefits of covid-19 vaccination and alleviate apprehension about the vaccine, to ensure its acceptance and encourage uptake across various audiences.
Objectives
x Create demand, promote acceptability and accessibility o...
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...
Toolkit regarding Zika Virus
17 February 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
WHO technical advisory group on behavioural insights and sciences for health, meeting report, 15 October 2020
27 May 2021
All countries should increase their level of preparedness, alert and response to identify, manage and care for new cases of COVID-19. Countries should prepare to respond to different public health scenarios, recognizing that there is no one-size-fits-all approach to managing cases and o...
Adaptable guidance, tools, trainings, and advocacy materials are being developed to support countries in preparing for COVID-19 vaccination. Please visit this page regularly for updates.
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...
Updated 20 Nov. 2020
Countries can use this checklist of hospital governance, structures, plans and protocols to rapidly determine the current capacities of hospitals to respond to the COVID-19 pandemic and to identify gaps and major areas that require investment and action for the development of h...
Robust clinical research capacity in low- and middle-income countries is key to stemming the spread of epidemics, according to a new report from the International Vaccines Task Force (IVTF). The report lays out how to develop the political support, financing and coordination required to build this c...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
